Management of obesity in kidney transplant candidates and recipients: A clinical practice guideline by the DESCARTES Working Group of ERA.
Management of obesity in kidney transplant candidates and recipients: A clinical practice guideline by the DESCARTES Working Group of ERA.
复制标题
DOI：
10.1093/ndt/gfab310
复制
发表时间：
2021-12-24
期刊：
影响因子：
--
通讯作者：
Nagler EV
中科院分区：
文献类型：
--
作者：
Oniscu GC;Abramowicz D;Bolignano D;Gandolfini I;Hellemans R;Maggiore U;Nistor I;O'Neill S;Sever MS;Koobasi M;Nagler EV
制定了《肾移植候选者和受者肥胖管理的临床实践指南》，以指导终末期肾病（ESKD）合并肥胖患者的护理决策。该文件考虑了定义肥胖的挑战，权衡了治疗肾移植候选人和接受者肥胖的干预措施，并反映了肥胖对等待名单可能性的影响及其对移植结果的影响。它旨在为与本主题相关的管理决策提供信息，并为共同决策提供背景。该指南是由欧洲肾脏协会的欧洲国家肾移植发展教育、科学和护理工作组制定的。该小组由选定的方法学家补充，以监督该项目，并在整个过程中为指南制定提供方法学专业知识。该指南针对的是治疗或照顾正在考虑进行肾移植或已接受供体肾移植的ESKD患者的任何医疗保健专业人员。这包括肾病学家、移植内科医生、移植外科医生、全科医生、透析和移植护士。本指南的制定遵循了明确的证据审查过程。治疗方法和指南建议是基于对相关研究的系统审查以及对证据质量和建议强度的评估，并遵循建议分级评估、制定和评价方法。讨论了证据的局限性，并提出了未来研究的领域。
The clinical practice guideline Management of Obesity in Kidney Transplant Candidates and Recipients was developed to guide decision-making in caring for people with end-stage kidney disease (ESKD) living with obesity. The document considers the challenges in defining obesity, weighs interventions for treating obesity in kidney transplant candidates as well as recipients and reflects on the impact of obesity on the likelihood of wait-listing as well as its effect on transplant outcomes. It was designed to inform management decisions related to this topic and provide the backdrop for shared decision-making. This guideline was developed by the European Renal Association’s Developing Education Science and Care for Renal Transplantation in European States working group. The group was supplemented with selected methodologists to supervise the project and provide methodological expertise in guideline development throughout the process. The guideline targets any healthcare professional treating or caring for people with ESKD being considered for kidney transplantation or having received a donor kidney. This includes nephrologists, transplant physicians, transplant surgeons, general practitioners, dialysis and transplant nurses. Development of this guideline followed an explicit process of evidence review. Treatment approaches and guideline recommendations are based on systematic reviews of relevant studies and appraisal of the quality of the evidence and the strength of recommendations followed the Grading of Recommendations Assessment, Development and Evaluation approach. Limitations of the evidence are discussed and areas of future research are presented.
影响因子：
4.6
作者：
Gwon JG;Choi J;Jung CW;Lee CH;Oh SW;Jo SK;Cho WY;Park JB;Huh KH;Ro H;Han S;Cho JH;Lee S;Yang J;Kim MG
通讯作者：
Kim MG